Looming trade wars and rising nationalism have stirred troubling memories of the 1930s. Will history repeat itself? Do we face the chaotic breakdown of the global economic system in the face of stagnation, protectionism and political tumult?
Jeremy Green argues that, although we face grave problems, globalization is not about to end. Setting today's challenges within a longer historical context, he demonstrates that the global economy is more interconnected than ever before and the costs of undoing it high enough to make a complete breakdown unlikely. Popular analogies between the 1930s and today are misleading. But the governing liberal ideology of globalisation is changing. It is mutating into a hard-edged nationalism that defends free markets while reasserting sovereignty and strengthening borders. This `national liberalism' threatens a much more dangerous disintegration, fuelled by inequality and ecological crisis, unless we radically rethink the international status quo.
This brilliantly original account of the discontents of globalization is a must-read both for concerned citizens and students of global political economy.
The Pharmaceutical Studies Reader is an engaging survey of the field that brings together provocative, multi-disciplinary scholarship examining the interplay of medical science, clinical practice, consumerism, and the healthcare marketplace. Draws on anthropological, historical, and sociological approaches to explore the social life of pharmaceuticals with special emphasis on their production, circulation, and consumption Covers topics such as the role of drugs in shaping taxonomies of disease, the evolution of prescribing habits, ethical dimensions of pharmaceuticals, clinical trials, and drug research and marketing in the age of globalization Offers a compelling, contextually-rich treatment of the topic that exposes readers to a variety of approaches, ideas, and frameworks Provides an accessible introduction for readers with no previous background in this area
Psychiatry: Past, Present, and Prospect brings together perspectives from a group of highly respected psychiatrists, each with decades of experience in clinical practice. The topics covered range from scientific discoveries of all kinds, advances in treatment, and conceptual breakthroughs. The highlights are countered by the fields negative sides: perennial indecisiveness about the boundaries of psychiatry; the limitations of a narrow approach to humansuffering; the retreat from the hope of a de-institutionalised, community-based psychiatry; the divide between biological treatments and psychotherapy; the technical and ethical complexities of psychiatric research; and the low priority given to psychiatry, especially but far from exclusively in less developedcountries. The result is a text full of collected wisdom which will promote the curiosity of mental health professionals about key developments in psychiatry over the past half century; sensitize the next generation of mental health professionals to the role they might play in advancing the state of knowledge about mental illness and its treatment during the course of their careers; and serve as a valuable archival resource for scholars.This collection of viewpoints from very experienced leaders in the field of psychiatry will prove fascinating reading for psychiatrists and allied mental health professionals, such as psychologists, psychiatric social workers, psychiatric nurses and occupational therapists, both trained and in training. It will also offer the interested laity a balanced account of psychiatrys evolution since the 1950s, and its likely prospects in the 21st century.
Evidence-based Paediatric and Adolescent Diabetes brings together an international group of paediatric diabetes specialists to address the cause, course and complications of all types of diabetes. From a careful review of the latest research, they propose the best possible evidence-based recommendations for the care of children and the youth with diabetes.
The text provides the reader with an understanding across three different levels:
o Reviews how strong the evidence is for recommending one approach over another
o Highlights areas where evidence is not based on the types of studies needed to provide `highgrade recommendations', but where there is a general consensus as to the most sensible approach
o Identifies the issues that remain inadequately addressed such that no definitive recommendations can be made
As the incidence of type 1 diabetes mellitus continues to increase worldwide, and type 2 is being seen in more young people, this timely volume will help a wide range of health care professionals deliver the best possible care to their young patients.